Dual-modal metabolic analysis reveals hypothermia-reversible uncoupling of oxidative phosphorylation in neonatal brain hypoxia-ischemia

Naidi Sun, Yu Sun, Rui Cao, Hong‐Ru Chen, Yiming Wang, Elizabeth M. Fugate, Marchelle R. Smucker, Yi-Min Kuo, P. Ellen Grant, Diana M. Lindquist, Chia‐Yi Kuan, Song Hu

Abstract

Hypoxia-ischemia (HI), which disrupts the oxygen supply-demand balance in the brain by impairing blood oxygen supply and the cerebral metabolic rate of oxygen (CMRO2), is a leading cause of neonatal brain injury. However, it is unclear how post-HI hypothermia helps to restore the balance, as cooling reduces CMRO2. Also, how transient HI leads to secondary energy failure (SEF) in neonatal brains remains elusive. Using photoacoustic microscopy, we examined the effects of HI on CMRO2 in awake 10-day-old mice, supplemented by bioenergetic analysis of purified cortical mitochondria. Our results show that while HI suppresses ipsilateral CMRO2, it sparks a prolonged CMRO2-surge post-HI, associated with increased mitochondrial oxygen consumption, superoxide emission, and reduced mitochondrial membrane potential necessary for ATP synthesis—indicating oxidative phosphorylation (OXPHOS) uncoupling. Post-HI hypothermia prevents the CMRO2-surge by constraining oxygen extraction fraction, reduces mitochondrial oxidative stress, and maintains ATP and N-acetylaspartate levels, resulting in attenuated infarction at 24 hours post-HI. Our findings suggest that OXPHOS-uncoupling induced by the post-HI CMRO2-surge underlies SEF and blocking the surge is a key mechanism of hypothermia protection. Also, our study highlights the potential of optical CMRO2-measurements for detecting neonatal HI brain injury and guiding the titration of therapeutic hypothermia at the bedside.

Introduction

Neonatal hypoxic-ischemic encephalopathy (HIE) is a primary cause of permanent brain injury in newborns. While therapeutic hypothermia (cooling the infant) is the established standard of care, the underlying mechanisms of the "latent period"—the window between the initial injury and the subsequent "secondary energy failure" (SEF)—have remained poorly understood. A significant challenge has been the difficulty of measuring the Cerebral Metabolic Rate of Oxygen (CMRO2) in small, moving subjects without the confounding effects of anesthesia. This study aims to map the real-time metabolic transitions from initial insult to SEF and identify how cooling interrupts this progression.

Methods and Experimental Design

The research team utilized a dual-modal analysis combining in vivo imaging with in vitro biochemical assays:

  • Multi-parametric Photoacoustic Microscopy (PAM): This technique uses laser-induced ultrasound to simultaneously measure blood flow, oxygen saturation, and hemoglobin concentration. To ensure metabolic accuracy, measurements were taken from awake, head-restrained P10 mice, avoiding anesthesia-induced metabolic shifts.
  • Mitochondrial Bioenergetics: Cortical mitochondria were purified to measure Oxygen Consumption Rate (OCR), reactive oxygen species (ROS) emission, and membrane potential.
  • HR-MAS NMR Spectroscopy: Used to quantify brain metabolites, including ATP and N-acetylaspartate (NAA), a marker of neuronal health.
  • Vannucci Model: A standard neonatal stroke model involving unilateral carotid artery ligation followed by hypoxia (10% O2).
Experimental setup for awake-mouse metabolic imaging involving a head-restrained mouse on a water-floated treadmill.

Key Insights: The Paradoxical Metabolic Surge

The study identified a critical "metabolic surge" following the initial oxygen deprivation. Rather than a slow recovery, the injured hemisphere experienced a massive rebound in CMRO2 that exceeded baseline levels. This surge represents oxidative phosphorylation (OXPHOS) uncoupling: mitochondria consume oxygen at high rates but fail to produce ATP. Instead, they generate heat and toxic superoxide (ROS), effectively "revving in neutral" and leading to cellular burnout.

Therapeutic hypothermia acts as a "metabolic clamp." By specifically constraining the Oxygen Extraction Fraction (OEF), cooling prevents this metabolic surge, thereby protecting mitochondria from oxidative stress and preserving essential ATP levels.

Key Results

  • Neuroprotection: Therapeutic hypothermia (32°C for 4 hours) significantly reduced infarct volume from 45.25 mm³ to 8.74 mm³ compared to normothermic controls.
  • Metabolic Dynamics: In normothermic mice, CMRO2 surged to nearly double the baseline post-HI before crashing during SEF. Hypothermia maintained CMRO2 at pre-injury levels.
  • Mitochondrial Integrity: At 5 hours post-HI, normothermic mice showed reduced mitochondrial membrane potential and high ROS emission. Hypothermic mice maintained mitochondrial health and higher ATP concentrations (0.64 vs 0.33 µmol/g).
  • Biomarkers: NMR confirmed that cooling preserved NAA and creatine levels, markers typically depleted during secondary energy failure.

Limitations and Clinical Outlook

While P10 mice are developmental analogs for term human infants, translating these findings requires careful consideration of human neurodevelopmental stages. Additionally, PAM imaging is currently restricted to the cortex (approx. 500–750 μm depth), leaving deeper structures like the basal ganglia unexamined.

Future clinical applications may involve bedside optical tools (such as NIRS) to detect these CMRO2 "surge" signatures early, allowing clinicians to titrate therapeutic cooling doses for individual infants.

Source: Sun, N., et al. (2024). Dual-modal metabolic analysis reveals hypothermia-reversible uncoupling of oxidative phosphorylation in neonatal brain hypoxia-ischemia. eLife. DOI: 10.7554/eLife.100129.1

Summary updated

Abstract

Abstract Hypoxia-ischemia (HI), which disrupts the oxygen supply-demand balance in the brain by impairing blood oxygen supply and the cerebral metabolic rate of oxygen (CMRO2), is a leading cause of neonatal brain injury. However, it is unclear how post-HI hypothermia helps to restore the balance, as cooling reduces CMRO2. Also, how transient HI leads to secondary energy failure (SEF) in neonatal brains remains elusive. Using photoacoustic microscopy, we examined the effects of HI on CMRO2 in awake 10-day-old mice, supplemented by bioenergetic analysis of purified cortical mitochondria. Our results show that while HI suppresses ipsilateral CMRO2, it sparks a prolonged CMRO2-surge post-HI, associated with increased mitochondrial oxygen consumption, superoxide emission, and reduced mitochondrial membrane potential necessary for ATP synthesis—indicating oxidative phosphorylation (OXPHOS) uncoupling. Post-HI hypothermia prevents the CMRO2-surge by constraining oxygen extraction fraction, reduces mitochondrial oxidative stress, and maintains ATP and N-acetylaspartate levels, resulting in attenuated infarction at 24 hours post-HI. Our findings suggest that OXPHOS-uncoupling induced by the post-HI CMRO2-surge underlies SEF and blocking the surge is a key mechanism of hypothermia protection. Also, our study highlights the potential of optical CMRO2-measurements for detecting neonatal HI brain injury and guiding the titration of therapeutic hypothermia at the bedside.
BibTeX
@misc{sun2024dual,
  author = {Naidi Sun and Yu Sun and Rui Cao and Hong‐Ru Chen and Yiming Wang and Elizabeth M. Fugate and Marchelle R. Smucker and Yi-Min Kuo and P. Ellen Grant and Diana M. Lindquist and Chia‐Yi Kuan and Song Hu},
  title = {{Dual-modal metabolic analysis reveals hypothermia-reversible uncoupling of oxidative phosphorylation in neonatal brain hypoxia-ischemia}},
  year = {2024},
  doi = {10.7554/elife.100129.1},
}
Figure